BSE filing, BSE: 544370. Summary written from the filing by ALFA Finder's alert engine.
Nukleus Office Solutions Ltd: key numbers
- Share price
- ₹170.00
- Market cap
- ₹68.54 Cr
- Revenue (annual)
- ₹35.48 Cr
- Net profit (annual)
- ₹2.14 Cr
- P/E (TTM)
- 32.1×Sector 36.4×
- Promoter holding
- 70.25%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nukleus Office Solutions Ltd
All →Nukleus Office Solutions Board Meeting Date
Nukleus Office Solutions will hold a board meeting on October 31, 2026. Agenda includes half-year results, MOA alteration and authorised capital increase.
Nukleus Office Solutions Management Change
Nukleus Office Solutions disclosed that SMP Mr. Anurag Gupta resigned as Lead Manager – Facilities. His tenure ends 30 October 2026 for personal reasons.
Nukleus Office Solutions Annual General Meeting
Nukleus Office Solutions Limited conducted its 7th Annual General Meeting on September 25, 2026. Shareholders considered agenda items including financial statement adoption and a new ESOP scheme.
Nukleus Office Solutions Other Announcement
Nukleus Office Solutions dispatched a Reg 36(1)(b) letter to shareholders without registered emails, providing a weblink and QR code for the FY 25-26 Annual Report. The letter also reminds physical shareholders to update KYC and dematerialise shares.
Nukleus Office Solutions Annual Report
Nukleus Office Solutions Limited has filed its Annual Report for the financial year 2025-26, including the notice for the 7th Annual General Meeting.
Nukleus Office Solutions Annual General Meeting
Nukleus Office Solutions Limited issued a notice for its 7th Annual General Meeting, scheduled for September 25, 2026, to discuss financial statements and ESOP scheme implementation.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.